封面
市场调查报告书
商品编码
1672800

全球合成生物学市场按产品、技术、最终用户和地区划分

Synthetic Biology Market, By Product, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球合成生物学市场规模预估为 219 亿美元,预计到 2032 年将达到 907.3 亿美元,2025 年至 2032 年的复合年增长率为 22.5%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 219亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 22.50% 2032 年价值预测 907.3亿美元
数字。 2025 年合成生物学市场份额(按地区划分)
合成生物学市场-IMG1

合成生物学是将工程原理应用于生物学的新兴领域。该领域涉及新型人工生物路径、生物体和设备的设计和构建,或对现有的自然生物系统的重新设计。合成生物学的主要应用包括开发燃料、化学品和材料的先进生物製造技术,以及开发用于农业、製药和环境解决方案的工程生物。研究人员正在致力于开发人工生物系统,以实现更有效率、更环保的生产过程。 DNA序列测定、基因组装和编辑技术的进步推动了该领域的快速发展,有可能解决医疗保健、能源和环境等领域的许多紧迫的全球挑战。

市场动态:

全球合成生物学市场受到该领域研发资金和投资增加、DNA定序和基因编辑技术的进步、生物製药需求不断增长以及代谢工程等技术发展等因素的推动。行业标准正在製定中,以确保合成生物学的负责任且安全的应用。然而,有关基因改造生物的监管问题和道德问题可能会抑制市场成长。合成生物学为解决药物发现、工业生物製造和环境修復等多个领域的挑战提供了机会。商业应用的发展、国际合作以及 DNA 合成和基因组工程成本效益的提高将支持市场扩张。

本研究的主要特点

  • 本报告对全球合成生物学市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还揭示了不同领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,涵盖了全球合成生物学市场主要企业的概况。
  • 本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球合成生物学市场报告涵盖该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球合成生物学市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件

第二章 市场概况

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 市场机会蓝图

第 3 章 关键见解

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • PEST分析
  • 波特的分析
  • 技术进步
  • 併购与合作场景
  • 近期产品核可
  • 进出口分析
  • 监管情景
  • 定价分析
  • COVID-19影响分析
  • 生产能力
  • 经销商状况
  • 投资与资金筹措
  • 品牌地图
  • 竞争概况
  • 公司定位分析
  • 热图分析

第 4 章。全球合成生物学市场依产品划分(2020-2032 年)

  • 寡核苷酸
  • 酵素
  • 合成细胞
  • 底盘有机体
  • 其他的

5. 全球合成生物学市场依技术划分(2020-2032 年)

  • 基因组工程
  • PCR 技术
  • 生物工艺技术
  • NGS技术
  • 生物资讯学
  • 奈米科技
  • 其他的

6. 全球合成生物学市场依最终用户划分(2020-2032 年)

  • 製药公司
  • 生技公司
  • CMO 和 CRO
  • 其他的

7. 全球合成生物学市场按地区划分(2020-2032 年)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第八章 竞争格局

  • 衝突的简介
  • 市场公司观点
  • 竞争仪錶板
  • 企业市场占有率分析:全球(2025 年)
  • 公司简介:全球合成生物学市场
  • Thermo Fisher Scientific
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs(UK)Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

第 9 章 命运之轮

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map(COM)

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI112

Global Synthetic Biology Market is estimated to be valued at USD 21.90 Bn in 2025 and is expected to reach USD 90.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 21.90 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 22.50% 2032 Value Projection: USD 90.73 Bn
Figure. Synthetic Biology Market Share (%), By Region 2025
Synthetic Biology Market - IMG1

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics:

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global synthetic biology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

  • Product:
    • Oligonucleotides
    • Enzymes
    • Synthetic Cells
    • Chassis Organism
    • Others
  • Technology:
    • Genome Engineering
    • PCR Technology
    • Bioprocessing Technology
    • NGS Technology
    • Bioinformatics
    • Nanotechnology
    • Others
  • End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • CMO & CRO
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • Synbio Technologies
    • Merck KGaA
    • Agilent Technologies Inc.
    • GenScript
    • Amyris
    • Eurofins Genomics GmbH
    • Integrated DNA Technologies Inc.
    • Codexis Inc.
    • EnBiotix Inc.
    • Synthego
    • New England Biolabs (UK) Ltd.
    • Scarab Genomics LLC
    • Genomatica Inc.
    • Novonesis Group
    • Bota Bio
    • Creative Biogene
    • Illumina, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Synthetic Biology Market, By Product, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Oligonucleotides, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Enzymes, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Synthetic Cells, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Chassis Organism, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Synthetic Biology Market, By Technology, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Genome Engineering, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • PCR Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Bioprocessing Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • NGS Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Bioinformatics, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Nanotechnology , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Synthetic Biology Market, By End User, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Pharmaceutical Companies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Biotechnology Companies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • CMO & CRO, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Synthetic Biology Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • GCC
    • Israel
    • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2025 - Global
  • Company Profiles - Global Synthetic Biology Market
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

9. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact